在自体主导多囊性脏疾病中,西丁和骨特性
Magdalena Jankowska1, Abdul Rashid Qureshi2, Mathias Haarhaus2
1Department of Nephrology, Transplantology and Internal Medicine, Faculty of Medicine, Medical University of Gdańsk, 80-210 Gdańsk, Poland.
与其他慢性病 (CKD) 类型相比,氧化应激的标记物pentosidine在自身主导多囊性病 (ADPKD) 患者中升高. 在ADPKD中,更高的托西丁与改变的骨质特性相关,这表明氧化应激和骨健康之间存在联系.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 骨的新陈代谢 骨的新陈代谢
- 氧化压力是一种氧化压力.
背景情况:
- 自体主导多囊性病 (ADPKD) 的特点是骨代谢变化和氧化应激.
- 托西丁是一种先进的糖化最终产品和氧化应激标志物,可能表明骨健康受损.
研究的目的:
- 为了研究ADPKD患者的托西丁水平.
- 为了在不同慢性病 (CKD) 病因和健康个体中比较托西丁水平.
- 评估pentosidine与ADPKD骨特征之间的关联.
主要方法:
- 在三个队列中对554名成年人进行横截面分析.
- 根据CKD病因和阶段 (G1-G5) 的分类,使用梅奥影像分类 (MIC) 阶段化ADPKD.
- 通过HPLC和ELISA量化血托西丁;使用微印记评估骨材料强度指数 (BMSi).
主要成果:
- 与其他CKD病因相比,ADPKD患者在CKDG1-G4和CKD5D阶段的血pentosidine水平显著更高.
- 索西丁与传统的骨生物标志物没有关联.
- 在ADPKD患者中,脏功能得到保护,托西丁的升高与骨矿物质密度和BMSi相关.
结论:
- 与其他CKD类型相比,Pentosidine水平在ADPKD中始终较高.
- 托西丁与皮层骨特性之间的关联表明它在ADPKD内的骨变化中的作用.
- 这些发现表明,在ADPKD中,一种新的途径将氧化应激和骨健康联系在一起.
更多相关视频
07:35Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
12:47Spectral Karyotyping to Study Chromosome Abnormalities in Humans and Mice with Polycystic Kidney Disease
Published on: February 3, 2012
相关概念视频
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Nephrons
Chronic Kidney Disease III: Interprofessional Care
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
